Advances in technology are changing some of the basic questions doctors ask when treating cancer.
“Does it matter if it's breast or lung or colon or leukemia - should we be treating tumors based on their mutations and not on their tissue of origin?” says Dr. Stan Lipkowitz of the National Cancer Institute.
Doctors in Charlotte and across the country are in the early stages of answering those questions. They’re focusing on the genetic mutations thought to be driving someone’s cancer, rather than the place it started.
For some patients in Charlotte, the results of this treatment have been remarkable.